📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: TiGenix

1.1 - Company Overview

TiGenix Logo

TiGenix

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative local regenerative medicine treatments for damaged and osteoarthritic joints, focusing on research and development of durable therapies validated through controlled clinical studies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to TiGenix

Salix Pharmaceuticals Logo

Salix Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceuticals focused on preventing and treating gastrointestinal disorders, licensing, developing, and marketing therapies including XIFAXAN for IBS-D and reducing overt hepatic encephalopathy recurrence; RELISTOR for opioid-induced constipation; TRULANCE for chronic idiopathic constipation and IBS-C; UCERIS for ulcerative colitis; MOVIPREP and PLENVU for colonoscopy bowel preparation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Salix Pharmaceuticals company profile →
Merus Labs Logo

Merus Labs

HQ: Canada Website
  • Description: Provider of pharmaceutical products across broad therapeutic classes, leveraging an opportunistic product acquisition strategy to source acquisition candidates and access targets not available to other players.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Merus Labs company profile →
Antibe Therapeutics Logo

Antibe Therapeutics

HQ: Canada Website
  • Description: Provider of novel anti-inflammatory drugs that improve existing, proven therapies, targeting diseases characterized by inflammation, pain, and vascular dysfunction. Offers a proprietary hydrogen sulfide platform; pipeline includes Otenaproxesul for acute pain with demonstrated gastrointestinal safety and efficacy in chronic pain, ATB-352 for specialized pain, and a program for mild-to-moderate inflammatory bowel disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Antibe Therapeutics company profile →
Eton Pharmaceuticals Logo

Eton Pharmaceuticals

HQ: United States Website
  • Description: Provider of proprietary formulations of approved molecules and pharmaceutical products to fulfill unmet patient needs. Develops and commercializes a diversified pipeline of around eight candidates in various stages. Receives milestone payments and royalties on commercial sales from seven products it developed and submitted regulatory applications for to the FDA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eton Pharmaceuticals company profile →
TargeGen Logo

TargeGen

HQ: United States Website
  • Description: Provider of vascular biology-focused small molecule kinase inhibitors targeting vascular leakage (edema), vascular proliferation (angiogenesis), and inflammation, offering treatments for human diseases such as heart attack, cancer, and eye diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full TargeGen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for TiGenix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to TiGenix

2.2 - Growth funds investing in similar companies to TiGenix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for TiGenix

4.2 - Public trading comparable groups for TiGenix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to TiGenix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About TiGenix

What does TiGenix do?

TiGenix is a provider of innovative local regenerative medicine treatments for damaged and osteoarthritic joints, focusing on research and development of durable therapies validated through controlled clinical studies.

Who are TiGenix's competitors?

TiGenix's competitors and similar companies include Salix Pharmaceuticals, Merus Labs, Antibe Therapeutics, Eton Pharmaceuticals, and TargeGen.

Where is TiGenix headquartered?

TiGenix is headquartered in Belgium.

How many employees does TiGenix have?

TiGenix has 1,000 employees 🔒.

When was TiGenix founded?

TiGenix was founded in 2010 🔒.

What sector and industry vertical is TiGenix in?

TiGenix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for TiGenix

Who are the top strategic acquirers in TiGenix's sector and industry

Top strategic M&A buyers and acquirers in TiGenix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for TiGenix?

Top strategic M&A buyers groups and sectors for TiGenix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in TiGenix's sector and industry vertical

Which are the top PE firms investing in TiGenix's sector and industry vertical?

Top PE firms investing in TiGenix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in TiGenix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in TiGenix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in TiGenix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to TiGenix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in TiGenix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for TiGenix?

The key public trading comparables and valuation benchmarks for TiGenix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for TiGenix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for TiGenix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in TiGenix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for TiGenix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in TiGenix's' sector and industry vertical?

Access recent funding rounds and capital raises in TiGenix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for TiGenix